Otani S, Ohnuma M, Kosei Ito, Matsushita Y. Cellular dynamics of distinct skeletal cells and the development of osteosarcoma. Frontiers in Endocrinology. 2023. 14
Qing Jiang, Xin Qin, Kenichi Nagano, Hisato Komori, Yuki Matsuo, Ichiro Taniuchi, Kosei Ito, Toshihisa Komori. Different Requirements of CBFB and RUNX2 in Skeletal Development Among Calvaria, Limbs, Vertebrae and Ribs. International Journal of Molecular Sciences. 2022. 23. 21. 13299-13299
飯居宏美, 近藤真帆, 伊藤公成, 中田晋. Suppression of Wnt pathway is involved in anticancer activity of GGCT knockdown in colorectal cancer cells. 日本癌学会学術総会抄録集(Web). 2023. 82nd
Yuki Date, Shohei Otani, Tomoya Ueno, Kosei Ito. Abstract 301: RUNX3 upregulatesc-MYCviamR1- an essential genomic element forp53-deficient osteosarcomagenesis. Molecular and Cellular Biology / Genetics. 2020
Advances in Experimental Medicine and Biology 962; RUNX Proteins in Development and Cancer
Springer 2017
Lectures and oral presentations (12):
TGFβ signaling facilitates Myc upregulation by Runx in p53-deficient osteosarcoma development
(2022)
p53 deficiency causes Myc dysregulation through a novel TGFβ-facilitated promoter switchingmechanism to instigate osteosarcoma development
(AACR Annual Meeting 2022 2022)
Oncogenic Runx1-Myc axis in p53-deficient thymic lymphoma
(EACR 2021 Virtual Congress (European Association for Cancer Research) 2021)
RUNX3 upregulates c-MYC via mR1-an essential genomic element for p53- deficient osteosarcoma-genesis
(AACR Annual Meeting 2020 2020)
Oncogenic Runx3 in osteosarcoma development
(RUNX-2019 conference 2019)